DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 1564210
Country | SPC | SPC Expiration |
---|---|---|
Lithuania | PA2013018 | ➤ Sign Up |
Netherlands | C300624 | ➤ Sign Up |
Denmark | CA 2013 00058 | ➤ Sign Up |
Luxembourg | 92307 | ➤ Sign Up |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1564210
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Aug 27, 2026 | Gilead Sciences Inc | GENVOYA | cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate |
➤ Sign Up | Aug 27, 2026 | Gilead Sciences Inc | STRIBILD | cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate |
➤ Sign Up | Aug 27, 2026 | Gilead Sciences Inc | VITEKTA | elvitegravir |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |